Ruey-Hwang Chou Selected Research

Tubulin

1/2016	A novel microtubule inhibitor, MT3-037, causes cancer cell apoptosis by inducing mitotic arrest and interfering with microtubule dynamics.
6/2015	The newly synthesized 2-arylnaphthyridin-4-one, CSC-3436, induces apoptosis of non-small cell lung cancer cells by inhibiting tubulin dynamics and activating CDK1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ruey-Hwang Chou Research Topics

Disease

32	Neoplasms (Cancer) 01/2021 - 01/2002
6	Breast Neoplasms (Breast Cancer) 01/2021 - 04/2009
5	Neoplasm Metastasis (Metastasis) 01/2021 - 04/2009
4	Hepatocellular Carcinoma (Hepatoma) 10/2018 - 01/2012
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 12/2006
2	Brain Neoplasms (Brain Tumor) 04/2022 - 03/2013
2	Hearing Loss (Hearing Impairment) 01/2022 - 06/2021
2	Inflammation (Inflammations) 01/2022 - 11/2016
2	Infections 10/2018 - 01/2012
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2017 - 01/2013
2	Triple Negative Breast Neoplasms 09/2014 - 01/2013
2	Chronic Hepatitis B 01/2014 - 01/2012
2	Wounds and Injuries (Trauma) 01/2014 - 04/2009
2	Adenocarcinoma of Lung 06/2011 - 04/2009
2	Carcinoma (Carcinomatosis) 04/2009 - 04/2002
1	Ototoxicity 01/2022
1	Periodontitis 07/2020
1	Macular Degeneration (Age-Related Maculopathy) 10/2018
1	Postoperative Hemorrhage 07/2018
1	Pain (Aches) 07/2018
1	Carcinogenesis 11/2016
1	Aphthous Stomatitis (Aphthous Ulcer) 01/2016
1	Ataxia Telangiectasia (Louis Bar Syndrome) 06/2015
1	Lymphoma (Lymphomas) 09/2014
1	Stroke (Strokes) 04/2013
1	Glioblastoma (Glioblastoma Multiforme) 03/2013

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2002
4	Peptides (Polypeptides)IBA 01/2020 - 01/2012
3	Pharmaceutical PreparationsIBA 11/2020 - 09/2014
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 06/2021
2	Suramin (Suramin Sodium)IBA 01/2021 - 11/2020
2	ErbB Receptors (EGF Receptor)IBA 01/2021 - 07/2014
2	MicroRNAs (MicroRNA)IBA 07/2020 - 05/2017
2	Biological ProductsIBA 08/2018 - 12/2006
2	Matrix Metalloproteinases (MMPs)IBA 07/2017 - 10/2015
2	AntioxidantsIBA 07/2017 - 12/2010
2	Histones (Histone)IBA 05/2017 - 07/2014
2	TubulinIBA 01/2016 - 06/2015
2	DNA-Activated Protein KinaseIBA 06/2015 - 09/2012
2	Messenger RNA (mRNA)IBA 01/2014 - 09/2012
2	Polysaccharides (Glycans)IBA 01/2014 - 01/2012
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2013 - 04/2009
2	Kallikreins (Kallikrein)IBA 06/2011 - 12/2006
1	Air Pollutants (Pollutants, Air)IBA 04/2022
1	RNA (Ribonucleic Acid)IBA 06/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Pentamidine (NebuPent)FDA LinkGeneric 01/2021
1	Enhancer of Zeste Homolog 2 ProteinIBA 07/2020
1	Chemokine ReceptorsIBA 07/2020
1	S100 Calcium-Binding Protein A4IBA 01/2020
1	Calcium-Binding ProteinsIBA 01/2020
1	Retinal Pigments (Pigments, Visual)IBA 10/2018
1	BAY 11-7085IBA 01/2018
1	Caspase 3 (Caspase-3)IBA 07/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2017
1	mangostinIBA 07/2017
1	Cytochromes c (Cytochrome c)IBA 07/2017
1	Caspase 9IBA 07/2017
1	CalciumIBA 11/2016
1	Anti-Allergic Agents (Antiallergic Agents)IBA 01/2016
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2016
1	amlexanox (Aphthasol)FDA Link 01/2016
1	Membrane Proteins (Integral Membrane Proteins)IBA 10/2015
1	Checkpoint Kinase 2IBA 06/2015
1	CSC-3436IBA 06/2015
1	Checkpoint Kinase 1IBA 06/2015
1	Phosphotransferases (Kinase)IBA 06/2015
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 09/2014
1	FucosyltransferasesIBA 04/2014
1	Globo-HIBA 04/2014
1	AntigensIBA 04/2014
1	CarbohydratesIBA 04/2014
1	OligosaccharidesIBA 01/2014
1	Advanced Glycation End ProductsIBA 01/2014
1	Cell Surface ReceptorsIBA 01/2014
1	Fetal Proteins (Fetoprotein)IBA 01/2014
1	Rosiglitazone (Avandia)FDA Link 04/2013
1	Immunoglobulins (Immunoglobulin)IBA 03/2013
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2013
1	FlavonoidsIBA 01/2013
1	fisetinIBA 01/2013
1	SB 203580IBA 01/2013
1	p38 Mitogen-Activated Protein KinasesIBA 01/2013
1	Tyrosine (L-Tyrosine)FDA Link 01/2013
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2013
1	4- carboxy- 5- (pyridyloxy- 5'- phosphate)prolineIBA 01/2013
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 01/2013
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2013
1	ChloridesIBA 01/2013

Therapy/Procedure

6	Therapeutics 01/2021 - 06/2015
2	Radiotherapy 03/2013 - 09/2012
1	Intravenous Administration 01/2022
1	Oral Hygiene (Dental Hygiene) 07/2020
1	Operative Time 07/2018
1	Length of Stay 07/2018
1	Transplantation 01/2014
1	Immunotherapy 03/2013
1	Drug Therapy (Chemotherapy) 03/2013
1	Photochemotherapy (Photodynamic Therapy) 01/2013